Your browser doesn't support javascript.
loading
Predisposing factors for advanced liver fibrosis in patients with sickle cell disease.
Manganas, Konstantinos; Delicou, Sophia; Xydaki, Aikaterini; Kourakli, Alexandra; Evliati, Loukia; Vlachaki, Efthymia; Klironomos, Evangelos; Diamantidis, Michail; Lafiatis, Ioannis; Kattamis, Antonios; Koskinas, John.
Afiliação
  • Manganas K; Thalassemia and Sickle Cell Unit, Hippokration General Hospital, Athens, Greece.
  • Delicou S; Thalassemia and Sickle Cell Unit, Hippokration General Hospital, Athens, Greece.
  • Xydaki A; Thalassemia and Sickle Cell Unit, Hippokration General Hospital, Athens, Greece.
  • Kourakli A; Thalassemia & Hemoglobinopathies Unit, Hematology Division, Department of Internal Medicine, University of Patras Medical School, University Hospital, Patras, Greece.
  • Evliati L; Thalassemia and Sickle Cell Unit, General Hospital of Athens "Evaggelismos", Athens, Greece.
  • Vlachaki E; Thalassemia and Sickle Cell Unit, Hippokration General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Klironomos E; Thalassemia and Sickle Cell Unit, "Venizelion" General Hospital, Heraklion, Greece.
  • Diamantidis M; Thalassemia and Sickle Cell Unit, General Hospital of Larissa, Larissa, Greece.
  • Lafiatis I; Thalassemia and Sickle Cell Unit, "Vostanio" General Hospital of Mytilene, Mytilene, Greece.
  • Kattamis A; "Agia Sophia" Children Hospital, First Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece.
  • Koskinas J; Department of Internal Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.
Br J Haematol ; 202(6): 1192-1198, 2023 09.
Article em En | MEDLINE | ID: mdl-37438880
ABSTRACT
Sickle cell disease (SCD) is one of the most common monogenic disorders worldwide and liver complications are common in this group of patients. Our study aims to highlight the prevalence of chronic liver complications and the main predisposing factors for advanced liver fibrosis in SCD patients. For this purpose, 219 patients from eight Thalassemia and Sickle Cell Units across Greece enrolled in our study and history of liver related disease complications was recorded, as well as a full laboratory and imaging analysis concerning their liver function. 13.6% of the patients had advanced liver fibrosis. The presence of liver fibrosis was significantly correlated with advanced age, male gender, cholelithiasis and higher LDH, γ-GT, INR, direct and indirect bilirubin levels. These patients had exhibited significantly more episodes of liver crises and acute intrahepatic cholestasis. No correlation was observed with right heart failure or previous viral hepatitis. Patients with advanced liver fibrosis were receiving a more intensive transfusion therapy for a longer period of time and had higher Liver Iron Concentration levels. Our study shows that liver complications and cirrhosis is a significant cause of morbidity in patients with SCD and it is primarily associated with intravascular hemolysis and vaso-occlusive phenomena and secondarily with iron overload.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anemia Falciforme / Hepatopatias Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anemia Falciforme / Hepatopatias Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article